Prot #D419NC00001: A Phase 1 Study of Durvalumab and IPH2201 in Adult Subjects with Select Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date2/6/172/6/23

Funding

  • MedImmune, LLC (Prot #D419NC00001)